ChromaDex Corporation (NASDAQ: CDXC)
$5.4200
-0.0700 ( -0.73% ) 166.0K
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
Market Data
Open
$5.4200
Previous close
$5.4900
Volume
166.0K
Market cap
$416.34M
Day range
$5.3650 - $5.6500
52 week range
$1.3600 - $7.9738
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 16, 2024 |
4 | Insider transactions | 1 | Dec 13, 2024 |
8-k | 8K-related | 13 | Dec 04, 2024 |
4 | Insider transactions | 1 | Nov 25, 2024 |
8-k | 8K-related | 19 | Nov 21, 2024 |
3 | Insider transactions | 3 | Nov 08, 2024 |
8-k | 8K-related | 37 | Oct 31, 2024 |
10-q | Quarterly Reports | 76 | Oct 31, 2024 |
3 | Insider transactions | 3 | Oct 23, 2024 |
4 | Insider transactions | 1 | Oct 23, 2024 |